July 2010 Latest Updates from ASCO and EHA

Published: Fri Apr 29, 2011 Updated:Wed Sep 14, 2011

We would like to thank Dr Tom Kouroukis for providing us with the latest hematology conference updates  

ASCO 2010


Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell translplant (ASCT) for multiple myeloma (MM): CALGB 1000104

Lenalidomide maintenance after transplantation for myeloma (IFM 2005-02 Study)

 

EHA 2010


A phase 3 study to determine the efficacy and safety of lenalidomide combined with melphalan and prednisone in patients > 65 years with newly diagnosed multiple myeloma (NDMM)

 

 

 

Sign-up for Our E-Newsletter